Blood Lead Concentration Correlates with All Cause, All Cancer and Lung Cancer Mortality in Adults: A Population Based Study

  • Published : 2013.05.30


Background: This study used National Health and Nutrition Examination Survey III to study the relationship between blood lead concentration and all cause, all cancer and lung cancer mortality in adults. Patients and Methods: Public use National Health and Nutrition Examination Survey (NHANES III) data were used. NHANES III uses stratified, multistage probabilistic methods to sample nationally representative samples. Household adult, laboratory and mortality data were merged. Sample persons who were available to be examined in aMobile Examination Center (MEC) were included in this study. Specialized survey analysis software was used. Results: A total of 3,482 sample participants with complete information for all variables were included in this analysis. For all cause death, the odds ratios (S.E.) for statistically significant variables were body mass index, 1.03 (1.01-1.06); 1.01 (1.01-1.01); blood lead concentration, 1.05 (1.01-1.08); poverty income ratio, 0.823 (0.76-0.89); and drinking hard liquor, 1.01 (1.00-1.02). For all cancer mortality, the odds ratios (S.E.) of the statistically signigicant variables were: age, 1.01 (1.01-1.01); blood lead concentration, 1.07 (1.04-1.12), black race, using non-Hispanic white as reference, 1.69 (1.12-2.56); and smoking, 1.02 (1.01-1.04). For lung cancer mortality, the odds ratios (S.E.) of the statistically significant variables were: age, 1.01(1.01-1.01); blood lead concentration, 1.09 (1.05-1.13); Mexican Americans, using non-Hispanic white as refrence, 0.33 (0.129-0.850); other races, 1.80 (0.53-6.18); and smoking, 1.03 (1.02-1.05). Conclusion: Blood lead concentration correlated with all cause, all cancer, and lung cancer mortality in adults.


  1. Chang SL, Harshman LC, Presti JC Jr (2010). Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey. J Clin Oncol, 28, 3951-57.
  2. Cohen SB (1997). An Evaluation of Alternative PC-Based Packages for the Analysis of Complex Survey Data. The American Statistician, 51, 285-92.
  3. Cooper WC (1988). Deaths from chronic renal disease in U.S. battery and lead production workers. Environ Health Perspect, 78, 61-63.
  4. Cooper WC, Wong O, and Kheifets L (1985). Mortality among employees of lead battery plants and lead-producing plants, 1947-1980. Scand J Work Environ Hlth, 11, 331-45.
  5. Ezzati-Rice TM, and Murphy RS (1995). Issues associated with the design of a national probability sample for human exposure assessment. Environ Hlth Perspect, 103, 55-9.
  6. Graubard BI , and Korn EL (1999). Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst, 91, 1005-16.
  7. Jemal A, Graubard BI, Devesa SS, Flegal KM (2002). The association of blood lead level and cancer mortality among whites in the United States. Environ Hlth Perspect, 110, 325-9.
  8. Jewell NP (2004). Statistics for Epidemiology (Boca Raton, Florida, Champman and Hall/CRC).
  9. Lemeshow S, Cook ED (1999). Practical considerations in the analysis of complex sample survey data. Rev Epidemiol Sante Publique, 47, 479-87.
  10. Malcolm D, and Barnett HA (1982). A mortality study of lead workers 1925-76. Br J Ind Med,39, 404-10.
  11. Menke A, Guallar E, Rohrmann S, et al (2010). Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol, 171, 583-92.
  12. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E (2006). Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation, 114, 1388-94.
  13. Rothman KJ, Greenland S, and Lash T L (2008). Modern Epidemiology, 3rd edn (Philadelphia, Pennsylvania, Lippincott Williams & Wilkins).
  14. Schober SE, Mirel LB, Graubard BI, Brody DJ, and Flegal KM (2006). Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Hlth Perspect, 114, 1538-41.
  15. Steenland K, and Boffetta P (2000). Lead and cancer in humans: where are we now? Am J Ind Med, 38, 295-9.<295::AID-AJIM8>3.0.CO;2-L
  16. Wong O, and Harris F (2000). Cancer mortality study of employees at lead battery plants and lead smelters, 1947-1995. Am J Ind Med, 38, 255-70.<255::AID-AJIM4>3.0.CO;2-8

Cited by

  1. Comparing the Metal Concentration in the Hair of Cancer Patients and Healthy People Living in the Malwa Region of Punjab, India vol.8, pp.1179-5549, 2014,
  2. Trends and variability in blood lead concentrations among US adults aged 20–64 years and senior citizens aged ≥65 years vol.23, pp.14, 2016,
  3. Trends and variability in blood lead concentrations among US children and adolescents vol.23, pp.8, 2016,
  4. Correlation between serum lead and thyroid diseases: papillary thyroid carcinoma, nodular goiter, and thyroid adenoma vol.27, pp.5, 2017,
  5. Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis pp.1476-5640, 2017,
  6. Urinary Lead Concentration Is an Independent Predictor of Cancer Mortality in the U.S. General Population vol.8, pp.2234-943X, 2018,